Anthony Sinclair

Anthony produces news stories, features and guides for Congress.net, with a focus on history and the US political system.

An El Niño Inflation Storm Threatens Portfolios As Climate Shock Looms Over Commodity Markets

Investors betting that U.S. inflation will ease once the Iran conflict ends and energy prices fall may be badly miscalculating their exposure to risk. A powerful El Niño weather pattern is expected to pick up where geopolitical disruptions leave off, threatening to drive global commodity prices significantly higher in the months ahead. Analysts at Marex,…

Read More
Inflation Relief Checks

Bank Of America (BAC) Warns Of Too Many Red Flags In U.S. Stocks And Tells Investors Where To Put Money Now

Bank of America (BAC) is urging investors to exercise greater caution toward U.S. equities as a growing number of internal bear market indicators flash warning signals simultaneously. In a research note, strategists led by Savita Subramanian said there are “too many red flags” and advised clients to “take profits” at current levels. The firm estimates…

Read More

New York Fed Survey Finds Household Financial Worries At Highest Point Since July 2022

U.S. households are growing increasingly anxious about their financial situations, with a key measure of consumer distress hitting its highest level in nearly four years. The Federal Reserve Bank of New York’s monthly Survey of Consumer Expectations, released Monday, showed a sharp deterioration in how Americans view their current financial standing. The share of respondents…

Read More

At 65 And Widowed, Here Is How To Decide When To Switch From Survivor Benefits To Your Own Social Security

Collecting Social Security survivor benefits while wondering whether to claim your own retirement benefits is a common and important financial dilemma for widows and widowers. Many Americans in this situation do not realize they have the flexibility to switch between benefit types at a strategically advantageous time. The Social Security Administration does not allow recipients…

Read More

Novo Nordisk’s (NVO) Wegovy Pill Crushes Eli Lilly’s (LLY) Foundayo In Early Prescription Race

Novo Nordisk’s oral Wegovy pill has surpassed three million prescriptions in just over five months, cementing its place among the strongest U.S. pharmaceutical launches by volume on record. The three million prescription milestone translates to roughly one prescription filled every five seconds, reflecting relentless consumer demand since the drug became available in January 2026. Wegovy…

Read More

Investors Flee Tech Stocks And Rotate Into Defensive Sectors As Rate Fears Return

Wall Street’s longest winning streak in three years came to an abrupt end as investors abandoned high-flying technology shares in dramatic fashion. A stronger-than-expected May jobs report reignited fears that U.S. interest rates could rise again before the end of the year, rattling equity markets broadly. The Nasdaq composite suffered its worst single-day decline in…

Read More